Join our newsletter. Sign up today

News

Publications and related articles about Lunaphore Technologies and the industry in general.

Lunaphore closes a CHF 23M Series C financing round


Lunaphore Technologies SA, a Swiss life-sciences company developing innovative next-generation equipment for cancer research and tissue diagnostics, announces the first closing of its Series C funding, amounting to CHF 23M. The round was led by the Japanese strategic investor PHC Holdings Corporation, a global healthcare company that owns Epredia, a leading provider of comprehensive solutions for precision cancer diagnostics.

Read the full press release


Categories: Press Releases

Share this

Hi! We use cookies to improve this website. By continuing to use our services, you are giving us your consent to use cookies. Learn more about our privacy policy and our terms of use.
I agree